Pharmaceuticals major Wockhardt Ltd today reported 28.84 per cent decline in consolidated net profit at Rs 304.45 crore for the third quarter ended December 31, 2013-14.
It had posted net profit of Rs 427.84 crore in the October-December quarter of 2012-13 fiscal, Wockhardt Ltd said in a filing to the BSE.
Its net sales during Q3, 2013-14 were down at Rs 1,236.35 crore, from Rs 1,435.04 crore in the year-ago quarter.
Meanwhile, in a separate filing, Wockhardt informed the BSE that its board has declared a second Interim Dividend of Rs 5 per equity share of face value of Rs 5 for the financial year 2013-14 on 109,751,153 equity shares of the company.
The board has also approved re-appointment of its Executive Director Huzaifa Khorakiwala and Managing Director Murtaza Khorakiwala for a period of five years from March 31 onwards.
Wockhardt scrip closed at Rs 413.20 on the BSE, up 3.42 per cent from their previous close.
